Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
omega-3 acid ethyl esters
- Development stage
- Approved
- Lead developer
- ImmunityBio
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Omega-3 acid ethyl esters is a small molecule lipid-regulating agent being investigated by ImmunityBio as a supportive component of the NANT Ovarian Cancer Vaccine combination immunotherapy. In the Phase 1b/2 QUILT-3.051 study, it is administered as part of a complex metronomic regimen alongside chemotherapy (e.g., paclitaxel, cyclophosphamide), monoclonal antibodies (avelumab, bevacizumab), and novel immunotherapies (ALT-803, haNK cells, and various viral/yeast-based vaccines). The ethyl esters of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are intended to modulate the tumor microenvironment and provide nutritional support in patients with epithelial ovarian cancer who have progressed after standard-of-care therapy.
- Brand names
- LovazaOmacor
- Other names
- omega-3 fatty acid ethyl estersomega3 fatty acid ethyl estersomega 3 fatty acid ethyl estersEPA/DHA ethyl esters
02
Targets
PPARG (Peroxisome proliferator-activated receptor gamma)PPARA (Peroxisome proliferator-activated receptor alpha)FFAR4 (Free fatty acid receptor 4)
Beyond the preview
Go deeper on omega-3 acid ethyl esters.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on omega-3 acid ethyl esters.